Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan;8(1):70-72.
doi: 10.1159/000518433. Epub 2021 Aug 26.

Disfiguring Hidradenitis Suppurativa of the Face

Gianmarco Capasso  1 , Gabriella Fabbrocini  1 , Claudio Marasca  1
Affiliations
Case Reports

Disfiguring Hidradenitis Suppurativa of the Face

Gianmarco Capasso et al. Skin Appendage Disord. 2022 Jan.

Abstract

Introduction: Hidradenitis suppurativa (HS) is a chronic, disfiguring, and debilitating inflammatory skin condition accompanied by pain, malodorous discharge, scarring, and a scarce quality of life. Skin folds are the most frequently affected areas, while the face is rarely involved.

Case presentation: We herein report a case of a man in his 40s affected by a severe form of HS for 15 years. Physical examination showed massive, bridged scarring located on the cheeks, temporal area, chin, nuchae, and scalp.

Discussion: Massive face scarring due to HS is an infrequent event and represents a further burden for patients affected by HS and a therapeutic challenge for clinicians due to the lack of codified guidelines. Novel therapies with lasers and combination therapies are emerging and may be beneficial for hypertrophic scarring in HS.

Keywords: Hidradenitis suppurativa; Hypertrophic scars; Laser; Quality of life.

PubMed Disclaimer

Conflict of interest statement

None of the contributing authors has any conflict of interest, including specific financial interests or relationships and affiliations relevant to the subject matter in the manuscript.

Figures

Fig. 1
Fig. 1
Massive, bridged scarring on the cheeks and temporal area.
See this image and copyright information in PMC

References

    1. Deckers IE, Kimball AB. The handicap of hidradenitis suppurativa. Dermatol Clin. 2016 Jan;34((1)):17–22. - PubMed
    1. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61:51–7. - PubMed
    1. Marasca C, Fabbrocini G, Barrea L, Capasso G, DI Guida A, Cinelli E, et al. Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature. Minerva Endocrinol. 2020 Dec;45((4)):345–53. - PubMed
    1. Poli F, Wolkenstein P, Revuz J. Back and face involvement in hidradenitis suppurativa. Dermatology. 2010;221((2)):137–41. - PubMed
    1. Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. 2003;56:451–61. - PubMed

Publication types